Thermo Fisher Scientific Inc (NYSE: TMO) has reported E.P.S. of $4.28 for its third fiscal quarter (ending September 30) versus $4.26 for the same period a year ago — an increase of 0%. However, this result fell short of the consensus estimate of $5.50 by $-1.22. For the latest four quarters through September 30, E.P.S. were $17.34 versus $16.01 for the same period a year ago — an increase of 8%.
Recent Price Action
Thermo Fisher Scientific Inc (NYSE: TMO) stock increased 1.7% on 10/22/25. The shares closed at $567.20. Moreover, unusually high trading volume at 159% of normal accompanied the advance. The stock has been weak relative to the market over the last nine months but has risen 7.9% during the last week.
Current PriceTarget Research Rating
Thermo Fisher Scientific has a current Value Trend Rating of D (Negative). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing inconsistent signals. Thermo Fisher Scientific has a neutral Appreciation Score of 41 but a poor Power Rating of 21, triggering the Negative Value Trend Rating.
Rating Review
In light of this new information we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment